Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Increased frequency of CD4+ cells expressing CD161 in cancer patients.

Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Dec 2006

Iliopoulou Eleni G, Karamouzis Michalis V, Missitzis Ioannis, Ardavanis Alexandros, Sotiriadou Nectaria N, Baxevanis Constantin N, Rigatos Gerasimos, Papamichail Michael, Perez Sonia A

Abstract excerpt

PURPOSE: Although the function of natural killer receptors on T cells infiltrating tumors and their potential effect on antitumor immunity has been investigated, little is known about T cells expressing NKR-P1A (CD161) in cancer patients. In the present study, we examined T cells expressing CD161 in the peripheral blood, the tumor tissue and in malignant effusions of patients with several types of malignancies....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Surface
Share to CD28 Antigens

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to CD3 Complex

Share to CD4-Positive T-Lymphocytes

Share to Cell Count

Share to Interleukins

Share to Lectins, C-Type

Share to Leukocytes, Mononuclear

Source

Identifiers

PMID: 17145807
DOI: 10.1158/1078-0432.CCR-06-0977

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Increased frequency of CD4+ cells expressing CD161 in cancer patients.PMID 17145807Read ↗

CD161, a promising Immune Checkpoint, correlates with Patient Prognosis: A Pan-cancer AnalysisSemantic proximity Read ↗

Identification of Anti-tumor Cells Carrying Natural Killer (NK) Cell Antigens in Patients With Hematological Cancers.Semantic proximity Read ↗

CD161 defines a transcriptional and functional phenotype across distinct human T cell lineages.Semantic proximity Read ↗

Impact of Aging on the Frequency, Phenotype, and Function of CD161-Expressing T Cells.Semantic proximity Read ↗

Multifunctional human CD56 low CD16 low natural killer cells are the prominent subset in bone marrow of both healthy pediatric donors and leukemic patients.Semantic proximity Read ↗

Expression of LLT1 and its receptor CD161 in lung cancer is associated with better clinical outcomeSemantic proximity Read ↗

Human CD56bright NK Cells: An Update.Semantic proximity Read ↗

Cytotoxic markers and frequency predict functional capacity of natural killer cells infiltrating renal cell carcinoma.Semantic proximity Read ↗

CD16+ as predictive marker for early relapse in aggressive B-NHL/DLBCL patientsSemantic proximity Read ↗

Phenotypic and functional exhaustion of circulating CD3+ CD56+ NKT-like cells in colorectal cancer patients.Semantic proximity Read ↗

NK Cell Education in Tumor Immune Surveillance: DNAM-1/KIR Receptor Ratios as Predictive Biomarkers for Solid Tumor OutcomeSemantic proximity Read ↗

CD56dimCD16neg cells are responsible for natural cytotoxicity against tumor targets.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.